Check out ACC video coverage from the second day of ACC.16. Top highlights include:
Over the next three days, the world of cardiology will descend upon my hometown of Chicago for ACC.16!
Many people were involved in making ACC.16 happen, from members, to staff, to partner societies and Chapters. I would particularly like to thank ACC.16 Chair Athena Poppas, MD, and Co-Chair Jeff Kuvin, MD, for their leadership. As a result of this collective effort, ACC.16 features an unprecedented number of opportunities for creating connections, igniting innovation and engaging in disruptive discussion around the latest in cardiovascular research.
Recent estimates project that as many as one in three American adults will have diabetes by 2050 unless additional steps are taken to prevent and treat the disease. Raising public awareness of the signs and symptoms of diabetes, as well as how to prevent it, is one of the most critical ways to have an impact on the disease. However, raising awareness among clinicians about the need for expanded interdisciplinary care in managing diabetes and related disorders is equally crucial.
When it comes to cardiovascular disease in particular, diabetes significantly increases the risk for heart attack, stroke, heart failure and cardiovascular death. Over the last several years the ACC has partnered on several efforts to raise awareness about the links between diabetes and heart disease, given the strong association between the two. At the crux of these efforts is the need to bring together health care providers from across the primary and specialty care continuum to reduce cardiometabolic risk factors through early assessment and targeted interventions. Continue reading
New research on the use of novel oral anticoagulants for atrial fibrillation (AFib) patients and statins for diabetes patients from the NCDR’s outpatient PINNACLE Registry will be presented during the American Heart Association’s (AHA’s) meeting in Orlando.
Three abstracts will look at gender differences in use of anticoagulants for AFib (Sunday, Nov. 8 at 4:45 p.m. ET); frequency and practice level variation in statin use among diabetes patients (Monday, Nov. 9 at 9:00 a.m. ET); and impacts of introducing novel oral anticoagulants to overall oral anticoagulation rates in AFib (Monday, Nov. 9 at 6:00 p.m. ET). (Check out the ACC’s complete coverage of these and other studies at ACC.org/AHA2015). Continue reading
This post was authored by Salim S. Virani, MD, PhD, FACC, and Julia M. Akeroyd, MPH.
Innovative health care delivery models will need to be utilized in order to accommodate the increase in Americans securing health care coverage under the Affordable Care Act, especially with projected shortages in both the specialist and non-specialist physician workforce. One proposed solution is to increase the scope of practice for advanced practice providers (APPs) – nurse practitioners and physician assistants. An important aspect of this discussion is whether the quality of care provided by APPs is comparable to that provided by physicians. Continue reading
The annual European Society of Cardiology (ESC) Congress not only provides opportunities to learn about the latest cardiovascular research from across Europe and the rest of the world, but it also creates a unique venue for cardiovascular leaders to come together to discuss opportunities for collaboration and innovation.
Over the course of the five-day meeting, I and other ACC leaders will have met with our counterparts from societies like ESC, the American Heart Association, the World Heart Federation and others; chaired several joint sessions with ESC touching on important trends in cardiovascular medicine; and given interviews with media from around the world addressing findings from the research being presented. In fact, just today, I had the privilege of chairing a Hotline Session presenting new research on Diabetes. Continue reading
As the new academic year commences, there is a palpable energy on the wards. Fresh-faced first year cardiology fellows, subspecialty fellows, and newly minted junior attendings excitedly (and nervously) begin a new chapter in their academic career. As I reflect back upon my first year in general cardiology training, beyond the incredible amount of clinical cardiology knowledge I’ve gained, the most satisfying aspect of my fellowship thus far has been the mentorship I’ve been fortunate to experience. Continue reading
This post was authored by Sanjeev Bhavnani, MD, chair of the ACC.15 session on Mobile Technology in Health Care.
On day one of the Future of Cardiovascular MedicineTrack at #ACC15, we experienced innovation in several forms – most of all among our participants who were actively tweeting, texting and engaging to convey their thoughts and comments through social media and virtual connections. Cardiology has always been strongest at its roots and if this is an example of the things to come, we are well positioned for the future. Continue reading
Yesterday the New York Times (NYT) published an article, ”Medicare Payments Surge for Stents to Unblock Blood Vessels in Limbs.” The article draws attention to the high volume of such procedures performed by a few individuals and should not be construed as implying a systemic problem among the broader community of interventional cardiologists.
The ACC has had clinical guidelines for peripheral artery disease (PAD) since 2006; an update was issued in 2011. The current guideline specifically recommends revascularization with a stent when the patient is at risk for losing a limb or after an exercise program and/or medication have failed to address lifestyle-limiting symptoms. Smoking cessation and attention to other risk factors for heart disease and stroke are also emphasized. Continue reading